Poliomyelitis
"Poliomyelitis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An acute infectious disease of humans, particularly children, caused by any of three serotypes of human poliovirus (POLIOVIRUS). Usually the infection is limited to the gastrointestinal tract and nasopharynx, and is often asymptomatic. The central nervous system, primarily the spinal cord, may be affected, leading to rapidly progressive paralysis, coarse FASCICULATION and hyporeflexia. Motor neurons are primarily affected. Encephalitis may also occur. The virus replicates in the nervous system, and may cause significant neuronal loss, most notably in the spinal cord. A rare related condition, nonpoliovirus poliomyelitis, may result from infections with nonpoliovirus enteroviruses. (From Adams et al., Principles of Neurology, 6th ed, pp764-5)
Descriptor ID |
D011051
|
MeSH Number(s) |
C02.782.687.359.764 C10.228.228.618.750 C10.228.854.525.850 C10.668.864
|
Concept/Terms |
Poliomyelitis- Poliomyelitis
- Poliomyelitis, Acute
- Acute Poliomyelitis
- Epidemic Acute Poliomyelitis
- Acute Poliomyelitis, Epidemic
- Poliomyelitis, Epidemic Acute
- Poliomyelitis Infection
- Infection, Poliomyelitis
- Infections, Poliomyelitis
- Poliomyelitis Infections
- Polio
- Polios
|
Below are MeSH descriptors whose meaning is more general than "Poliomyelitis".
Below are MeSH descriptors whose meaning is more specific than "Poliomyelitis".
This graph shows the total number of publications written about "Poliomyelitis" by people in this website by year, and whether "Poliomyelitis" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 | 1997 | 2 | 0 | 2 | 1998 | 1 | 0 | 1 | 2001 | 0 | 1 | 1 | 2004 | 1 | 0 | 1 | 2007 | 1 | 0 | 1 | 2012 | 1 | 0 | 1 | 2013 | 0 | 1 | 1 | 2014 | 1 | 0 | 1 | 2015 | 1 | 0 | 1 | 2016 | 2 | 0 | 2 | 2017 | 1 | 1 | 2 | 2018 | 1 | 1 | 2 | 2020 | 2 | 0 | 2 | 2022 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Poliomyelitis" by people in Profiles.
-
Russo GB, Goyal T, Tyler K, Thakur KT. Re-Emergence of Poliovirus in the United States: Considerations and Implications. Ann Neurol. 2022 11; 92(5):725-728.
-
Franco-Paredes C, Rodriguez-Morales AJ, Henao-Mart?nez AF, Carrasco P, Tuells J. The growing threat of wild poliovirus 1 and vaccine-derived cases in the COVID-19 era. Lancet Infect Dis. 2022 10; 22(10):1412-1414.
-
Franco-Paredes C, Henao-Martinez AF, Chauhan L, Rodriguez-Morales AJ, Khan MI. Current Challenges to Achieving a Polio Free World. Ann Acad Med Singap. 2020 Sep; 49(9):704-706.
-
Franco-Paredes C, Santos-Preciado JI, Henao-Martinez AF, Rodriguez-Morales AJ, Carrasco P. Preventing paralytic polio caused by vaccine-derived poliovirus type 2. Lancet Infect Dis. 2020 01; 20(1):21-22.
-
Gaensbauer JT, Gast C, Bandyopadhyay AS, O'Ryan M, Saez-Llorens X, Rivera L, Lopez-Medina E, Melgar M, Weldon WC, Oberste MS, R?ttimann R, Clemens R, Asturias EJ. Impact of Maternal Antibody on the Immunogenicity of Inactivated Polio Vaccine in Infants Immunized With Bivalent Oral Polio Vaccine: Implications for the Polio Eradication Endgame. Clin Infect Dis. 2018 10 30; 67(suppl_1):S57-S65.
-
Qi W, Orgel S, Francon A, Randolph TW, Carpenter JF. Urea Improves Stability of Inactivated Polio Vaccine Serotype 3 During Lyophilization and Storage in Dried Formulations. J Pharm Sci. 2018 08; 107(8):2070-2078.
-
Bandyopadhyay AS, Asturias EJ, O'Ryan M, Oberste MS, Weldon W, Clemens R, R?ttimann R, Modlin JF, Gast C. Exploring the relationship between polio type 2 serum neutralizing antibodies and intestinal immunity using data from two randomized controlled trials of new bOPV-IPV immunization schedules. Vaccine. 2017 12 19; 35(52):7283-7291.
-
Lopez-Medina E, Melgar M, Gaensbauer JT, Bandyopadhyay AS, Borate BR, Weldon WC, R?ttimann R, Ward J, Clemens R, Asturias EJ. Inactivated polio vaccines from three different manufacturers have equivalent safety and immunogenicity when given as 1 or 2 additional doses after bivalent OPV: Results from a randomized controlled trial in Latin America. Vaccine. 2017 06 16; 35(28):3591-3597.
-
Wright PF, Connor RI, Wieland-Alter WF, Hoen AG, Boesch AW, Ackerman ME, Oberste MS, Gast C, Brickley EB, Asturias EJ, R?ttimann R, Bandyopadhyay AS. Vaccine-induced mucosal immunity to poliovirus: analysis of cohorts from an open-label, randomised controlled trial in Latin American infants. Lancet Infect Dis. 2016 Dec; 16(12):1377-1384.
-
Asturias EJ, Bandyopadhyay AS, Self S, Rivera L, Saez-Llorens X, Lopez E, Melgar M, Gaensbauer JT, Weldon WC, Oberste MS, Borate BR, Gast C, Clemens R, Orenstein W, O'Ryan G M, Jimeno J, Clemens SA, Ward J, R?ttimann R. Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial. Lancet. 2016 Jul 09; 388(10040):158-69.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|